Mohammad Javad Khosousi Sani

Dr. Mohammad Javad Khosousi Sani

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in ACR Open Rheumatology
Verified
Journal Article
Open access
PDF file
BGBanafsheh Ghavidel‐Parsa
Banafsheh Ghavidel‐Parsa
ABAli Bidari
Ali Bidari
ZAZahra Atrkarroushan
Zahra Atrkarroushan
MSMohammad Javad Khosousi Sani
Mohammad Javad Khosousi Sani
Objective: Nociplastic concept incorporates a broad continuum of pain phenotypes shared with clinical peculiarity. This study aimed to develop and validate a diagnostic tool, the preliminary Nociplastic‐based Fibromyalgia Features (NFF), to detect fibromyalgia (FM) in patients with chronic pain.Methods: Items requiring yes or no responses and relating to the most relevant clinical nociplastic pain (NP) features of FM were compiled by a group of expert rheumatologists. The provisional list was tested in a prospective study on 185 consecutive patients with chronic pain (126 patients with FM and 59 patients with non‐FM non‐inflammatory chronic pain) diagnosed based on expert decision. Identification of the most discriminant combinations of items for FM and the calculation of their sensitivity and specificity were based on both univariate and multivariate (stepwise logistic regression) analyses. All participants were investigated through the final NFF, the 2011 American College of Rheumatology (ACR) criteria, and the 2016 ACR criteria. NFF performance was assessed with receiver operating characteristic curve analysis.Results: Based on multivariate analyses, we retained only seven items in the final version of the NFF. A cut‐off score of 4 (corresponding to the number of positive items) gave the highest rate of correct identification of patients (85%), with a sensitivity of 82% and a specificity of 91%. The NFF showed the highest concordance rate with expert diagnosis (85%) and the lowest value (77%) with the ACR 2016 criteria.Conclusion: The preliminary NFF with respect to the various aspects of NP showed good performance for detection of the FM in the clinical setting. This tool may provide a more pragmatic approach to the timely diagnosis of FM.

7 January 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
BGBanafsheh Ghavidel-Parsa
Banafsheh Ghavidel-Parsa
ABAli Bidari
Ali Bidari
STSepehr Tohidi
Sepehr Tohidi
ISIrandokht Shenavar
Irandokht Shenavar
ELEhsan Kazemnezhad Leyli
Ehsan Kazemnezhad Leyli
MSMohammad Javad Khosousi Sani
Mohammad Javad Khosousi Sani

30 November 2021 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
STSepehr Tohidi
Sepehr Tohidi
EBElham Bidabadi
Elham Bidabadi
MSMohammad Javad Khosousi Sani
Mohammad Javad Khosousi Sani
MAMelika Amoukhteh
Melika Amoukhteh
MKMaryam Kousha
Maryam Kousha
TSTamkin Shahraki
Tamkin Shahraki
Sepehr Tohidi, Elham Bidabadi, Mohammad-Javad Khosousi, Melika Amoukhteh, Maryam Kousha, Parham Mashouf, Tamkin Shahraki. Clin Psychopharmacol Neurosci 2021;19:712-20. https://doi.org/10.9758/cpn.2021.19.4.712

22 August 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
BGBanafsheh Ghavidel-Parsa
Banafsheh Ghavidel-Parsa
ABAli Bidari
Ali Bidari
ARAshkan Rahimi
Ashkan Rahimi
FGFaeze Gharibpoor
Faeze Gharibpoor
MSMohammad Javad Khosousi Sani
Mohammad Javad Khosousi Sani

3 May 2022 in BMC Rheumatology
Verified
Journal Article
Open access
PDF file
BGBanafsheh Ghavidel-Parsa
Banafsheh Ghavidel-Parsa
MSMohammad Javad Khosousi Sani
Mohammad Javad Khosousi Sani
STSepehr Tohidi
Sepehr Tohidi
ABAli Bidari
Ali Bidari
SSSaman Soltani
Saman Soltani
Ali MontazeriAli Montazeri
Ali Montazeri
Background: The Invalidation Illness Inventory (3*I) is an instrument that assesses invalidation (including discounting and lack of understanding dimensions) experienced by patients with rheumatic disorders. This study aimed to translate and validate the 3*I in Iran. Methods: Following translation of the 3*I into the Iranian language (Persian), a cross-sectional study was conducted. A consecutive sample of females with chronic non-inflammatory rheumatic painful diseases completed the questionnaire. Patients also completed the Revised Symptom Impact Questionnaire (SIQR) and the Short Form Health Survey-12 (SF-12). To examine convergent validity, the correlation between the 3*I, the SIQR, and the SF-12 was assessed. The reliability of the 3*I was examined by internal consistency (the Cronbach's alpha coefficient) and intraclass correlation coefficient (ICC). Results: In all 196 patients participated in the study. The mean (SD) age of patients was 45.62 ± 10.70 years. Several significant correlations between the Invalidation Illness Inventory (discounting/lack of understanding) with the symptom impact (SIQR) and the short form health survey (SF-12) were observed lending support to the convergent validity of the 3*I. The Cronbach’s alpha coefficients were acceptable for most dimensions and sources, ranging from 0.52 to 0.88. Most ICC values for the dimensions of 3*I were above 0.75. Conclusions: The findings indicated that the Persian version of Illness Invalidation Inventory (3*I) is a valid instrument for invalidation assessment in patients with chronic pain. Given the high frequency of perceived invalidation among patients with rheumatic painful disorders, serious attention is needed to the issue in clinical and research settings.

14 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
PRPegah Rashidian
Pegah Rashidian
FPForough Heidarzad Pahlaviani
Forough Heidarzad Pahlaviani
SMSeyedsina Moghimnejadhosseini
Seyedsina Moghimnejadhosseini
NCNikitha Chellapuram
Nikitha Chellapuram
KSKavya Priya Somu
Kavya Priya Somu
AHAli Fatehi Hassanabad
Ali Fatehi Hassanabad
Background: Artificial intelligence is increasingly influencing health care and policy, yet the global research landscape linking artificial intelligence and health care policy remains underexplored. This study aimed to map publication trends, major contributors, collaboration networks, citation structures, and emerging themes in this field. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection. The search was performed on 3 May 2026, and covered publications from 2000 to 3 May 2026. The final dataset included 347 peer-reviewed English-language original research and review articles. Biblioshiny, VOSviewer, and CiteSpace were used to analyze publication trends, country and institutional contributions, author and journal productivity, collaboration networks, citation and co-citation structures, keyword patterns, and thematic evolution. Results: Publications increased markedly after 2020 and reached their highest annual output in 2025. The 2026 publication count was lower because data for that year were partial at the time of database retrieval. Researchers from 82 countries and 900 institutions contributed to the field, with the United States leading in output, followed by China, England, Canada, and India. Harvard Medical School was the most productive institution, whereas Harvard University had the highest institutional centrality. Frontiers in Public Health published the most articles, and PLOS ONE was the most frequently co-cited journal. The most cited article was “Artificial intelligence and the future of global health.” Key research themes included machine learning, COVID-19, health policy, risk, large language models, interpretable machine learning, neural network-assisted screening, socioeconomic perspectives, and public health applications. Conclusions: Research on artificial intelligence and health care policy has expanded rapidly, particularly in recent years, and is increasingly centered on predictive modeling, public health decision-making, and emerging artificial intelligence technologies. These findings highlight influential contributors, evolving themes, and future directions for researchers, policymakers, and health care leaders.